Invivo therapeutics holdings corp. (NVIV)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,623

-

-

-

-

-

-

-

-

Cash flows from operating activities:
Net loss

-2,414

-3,372

-2,679

-3,144

-2,635

-2,525

-3,175

-12,939

-4,784

-4,664

-9,350

-6,340

-6,391

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10,443

-15,830

-

-1,212

-3,646

-5,103

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

11

13

12

16

16

16

17

18

40

8

123

129

135

131

133

138

146

157

175

174

178

184

190

183

195

Amortization of operating lease right-of-use assets

69

68

66

66

65

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on impairment of fixed assets

-

-

-

-

-

0

0

0

-48

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivatives loss

-

-

-

-

-

765

-1,967

-10,186

-12

-3

-3,059

554

241

1,381

-336

595

-1,047

545

3,591

-4,654

-10,286

-4,508

3,005

1,127

0

Non-cash interest expense

-

-

-

-

-

-

0

1

1

3

0

1

1

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of asset

-

-

-

-

-

-

-

-

25

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock issued to 401(k) plan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

58

51

-

-

-

-

-

-

-

-

Common stock issued for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

195

0

0

282

Common stock issued to 401(k) plan

-

-

-

-

-

0

0

0

6

29

41

62

51

-

-

-

-

-

-

-

-

-

-

-

-

Common stock issued to 401(k) plan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

52

53

-

34

43

41

Share-based compensation expense

70

65

68

68

67

77

85

150

306

492

1,031

1,268

1,315

1,492

1,175

1,243

1,153

1,052

1,373

976

1,265

452

682

761

835

Non-cash investment (income) expense, net

-

-

-

-

-1

-

-

-

-

-

10

-20

12

-291

293

-30

-70

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-61

50

1

0

-231

Prepaid expenses

590

-339

-624

22

674

-1,038

255

263

443

65

-182

-283

489

38

-269

65

433

-84

-129

-146

-529

41

-36

-67

425

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

16

312

-1

-3

0

0

-2

-1

-1

-1

-1

-1

Accounts payable

46

121

36

-203

173

-464

365

-314

240

-282

392

-160

27

454

-3

121

-83

-276

-156

160

224

-142

119

-112

-195

Operating lease liability

-71

-70

-65

-35

26

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other liabilities

-843

404

176

-51

-397

-145

-1,557

660

906

17

-72

447

-536

223

508

228

512

-1,144

500

45

320

-307

-64

179

-56

Net cash used in operating activities

-3,722

-1,889

-1,762

-3,305

-3,358

-2,987

-2,553

-3,079

-3,693

-4,101

-4,603

-4,839

-6,140

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from investing activities:
Purchases of marketable securities

-

-

-

-

-

-

-

-

-

0

0

1,495

6,761

-

-

-

-

-

-

-

-

-

-

-

-

Sales of marketable securities

-

-

-

-

-

-

-

-

-

733

6,800

6,350

5,950

-

-

-

-

-

-

-

-

-

-

-

-

Disposals of property and equipment

-

-

-

-

-

-

-

-

25

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,157

-

-3,826

-4,234

-2,913

-4,219

-3,220

-3,651

-4,194

Purchases of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

10,929

1,822

3,713

2,452

-

-

-

-

-

-

-

-

Sales of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

11,465

-4,810

3,100

2,760

-

-

-

-

-

-

-

-

Purchases of property and equipment

-

-

-

-

-

-

-

-

-

11

0

38

16

11

23

23

50

-

-

-

-

33

9

-30

35

Net cash used in investing activities

-

-

-

-

-

0

0

-90

25

722

6,800

4,817

-827

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from financing activities:
Net cash (used in) provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

258

-

-

-

-

12

-9

30

-35

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

0

0

9

17

0

155

0

36

59

31

847

131

-

-

-

-

Proceeds from issuance of stock under ESPP

-

0

0

0

1

0

1

0

3

0

22

0

29

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of warrants

286

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

923

4,046

2,819

-

-

-

-

Principal payments on capital lease obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18

0

0

3

Repayment of loan payable

-

0

0

0

100

116

114

412

110

108

107

105

103

101

100

98

96

-

-

-

-

-

-

-

-

Repayment of loan payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

94

43

18

-

-

-

-

Repayment of note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19

18

Repurchase of warrants

-

-

-

-

-

0

0

0

14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock and warrants, net of commissions and issuance costs

6,035

-

-

-

-

0

0

14,001

2,510

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-5

29,910

3,442

0

0

11,038

-173

161

14,514

116

Net cash (used in) provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29,850

-

860

4,832

13,970

32

13

14,625

95

Net cash (used in) provided by financing activities

6,321

367

0

0

-99

-40

-68

13,599

2,389

-145

-85

-96

-57

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in cash and cash equivalents and restricted cash

2,599

-1,534

-1,762

-3,305

-3,457

-3,027

-2,621

10,430

-1,279

-3,524

2,112

-118

-7,024

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,797

-10,889

-4,721

25,951

-

-

598

11,057

-

-3,216

11,004

-4,134

Supplemental disclosure of cash flow information and non-cash investing and financing activities:
Cash paid for interest

-

0

0

0

1

9

10

11

14

15

16

20

20

49

0

26

28

24

33

31

33

55

12

33

32

Fair value of warrants issued in connection with the 2020 Offering

3,683

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash issuance of common stock for warrants

-

-

-

-

-

0

0

0

287

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Right-of-use assets and lease liability recorded upon adoption of ASC 842

-

0

0

0

1,475

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reclassification of derivative warrant liability to additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,576

4,866

-

-

-

-